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Abstract
Background: The adaptive immune response intrinsically depends on hypervariable human leukocyte antigen
(HLA) genes. Concomitantly, correct HLA phenotyping is crucial for successful donor-patient matching in organ
transplantation. The cost and technical limitations of current laboratory techniques, together with advances in next-
generation sequencing (NGS) methodologies, have increased the need for precise computational typing methods.
Results: We tested two widespread HLA typing methods using high quality full genome sequencing data from 150
individuals in 50 family trios from the Genome Denmark project. First, we computed descendant accuracies
assessing the agreement in the inheritance of alleles from parents to offspring. Second, we compared the
locus-specific homozygosity rates as well as the allele frequencies; and we compared those to the observed values
in related populations. We provide guidelines for testing the accuracy of HLA typing methods by comparing family
information, which is independent of the availability of curated alleles.
Conclusions: Although current computational methods for HLA typing generally provide satisfactory results, our
benchmark – using data with ultra-high sequencing depth – demonstrates the incompleteness of current reference
databases, and highlights the importance of providing genomic databases addressing current sequencing
standards, a problem yet to be resolved before benefiting fully from personalised medicine approaches HLA
phenotyping is essential.
Keywords: HLA genotyping, NGS, Clinical genomics, Population genetics, Prediction
Background
The immune system is the forefront defence of higher or-
ganisms against disease. To perform its function, the im-
mune system maintains a complex equilibrium between
identifying a variety of external pathogens and recognising
the organism’s own tissue. This process is carried out by
the adaptive immune system [1–3]. The hallmark of the
immune responses is the recognition of the offending
antigen by the host cells through the major histocompati-
bility complex (MHC). In humans, it is known as the hu-
man leukocyte antigen (HLA) system and is located
within a 3.6 Mb region on chromosome 6 (6p21.3) [3–5].
This region contains roughly 220 genes, which can be di-
vided in HLA-like coding genes and non-HLA coding
genes depending on their function and structure [6]. The
accurate classification of the specificities of the HLA mol-
ecules based on their structural properties is still a matter
of debate [7–9].
Traditionally, the HLA super-locus has been divided in
five genomic sub-regions [10]. Within the encoded genes,
further distinction is made between the so-called classical
MHC genes, which encode the functional, epitope pre-
senting molecules; and much less polymorphic, accessory
non-classical genes [11, 12]. The class I classical MHC
genes HLA-A, HLA-B and HLA-C, are expressed in all
nucleated cells and are known to bind proteins from intra-
cellular invading pathogens [13, 14]. The class II region,
meanwhile, encodes α and β chain genes of the HLA type
II dimers. These are primarily expressed in the so-called
professional antigen-presenting cells (dendritic cells, mac-
rophages and B cells) and have evolved to recognize ex-
ogenous proteins. The dimeric nature of the functional
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MHC-II complex and the copy-number variation of one
of the loci (HLA-DRB) make this region particularly com-
plicated [15]. The last gene-rich region, the class III re-
gion, encodes other conserved non-HLA genes with
immune related functions. Cytokines represent a charac-
teristic example of this category [6]. There are two add-
itional regions, extended class I and extended class II,
whose contributions to the gene count are minimal and
are often disregarded [10]. Typically, for transplantation
purposes only the classical genes are tested, there is an on-
going discussion on the role of non-classical genes in
transplantation failure [11, 12].
The hypervariability of the HLA region is key to the
detection of a wide variety of pathogens and the activa-
tion of a cascade of defence mechanisms [10]. Owing to
the selective pressure associated with immune functions,
linkage disequilibrium patterns and allele frequencies are
highly differentiated across populations [16]. These
genes are segregated as a haplotype in a Mendelian fash-
ion, making them suitable for population studies, as spe-
cific gene patterns and haplotypes are characteristic of
geographic regions [17].
Several studies have related the variation of the HLA re-
gion to different diseases, including cancer [18] and type I
diabetes [19]. As already mentioned, the region is a key
determinant in the success of transplantation; allotrans-
plants depend on equivalent HLA serotypes between indi-
viduals when no syngenic organ is available to avoid
immune rejection of the organ [20]. All these scenarios
need an accurate characterization of HLA genes. HLA
typing, the process of addressing the HLA of an individ-
ual, is hindered by the complexity and hypervariability of
the HLA region as discussed above [21]. Previous efforts
[22–25] have tried to overcome the problems by matching
with high accuracy those domains that directly interact
with the antigen (exons 2 and 3 for HLA class I, and exon
2 for HLA class II), but this approach has proven to be in-
sufficient alone [26]. Furthermore, while HLA typing and
HLA gene validation are done routinely through molecu-
lar genotyping methods [27–29], the large and rapidly
growing number of described HLA alleles are rendering
them obsolete and unable to meet current clinical and re-
search throughput demands [14, 30].
Automatic typing using computational methods has arisen
as a possible solution to the expensive and time-consuming
genotyping methods. Bioinformatic methods are more af-
fordable than their experimental counterparts and benefit
greatly from the constant development of algorithms in the
field of computational genomics.
Methods for automatic typing of HLA regions are nor-
mally divided into assembly or alignment-based methods,
according to whether the sequencing reads are either
aligned to a reference, or the true alleles are predicted
through probabilistic models [31]. Examples from both
categories have been extensively benchmarked using cu-
rated data [31–33]. These data sets, which are considered
gold standards, are obtained by PCR amplification using ei-
ther already known alleles as primers or through Sanger se-
quencing, and then compared against an HLA database for
designation. However, the relation between the gold stand-
ard and the database content presents problems. First, there
is a large overlap between benchmarking cohorts [31]. Sec-
ond, although they are useful for comparison of methods,
the results obtained do not reflect the potential behaviour
of the methods with different samples, especially if the new
cohorts present different genetic backgrounds.
Two methods consistently produce the most accurate
predictions of HLA typing: Optitype [25] and Polysolver
[33]. Optitype identifies reads that map to exons 2 and 3
of the HLA class I alleles to select the most likely HLA
class I allele from a custom database. Similarly, Polysolver
[33] relies on a Bayesian probabilistic model to reassign
reads that failed to map to the consensus reference gen-
ome. Here we present an analysis of the performance of
two different alignment-based methodologies to
characterize HLA type I alleles. We predict HLA alleles
from high-depth, high-coverage sequencing data from a
cohort of 50 Danish trios (father, mother, and child) in the
context of the Genome Denmark project [34, 35]. The
Genome Denmark project on these data has included,
among other analysis, novel variation discovery [36] and
therefore will not be covered in this publication. The Da-
nish population is quite homogeneous and shows overall
genomic resemblance to neighbouring countries [35]. This
admixture is coherent with the history of the country [37].
Due to the quality of the assembly, this cohort constitutes
a relevant resource for testing the robustness of the
methods and for evaluating the effective coverage of the
reference databases. Two different metrics evaluate differ-
ent aspects of the accuracy of allele imputation. Our re-
sults validate the performance of the typers with a
genetically different cohort, and reflect the importance of
extending the current databases to achieve a better accur-
acy, with the prospect of using these methods in current
medical practice. Finally, we compare the Danish popula-
tion to other neighbouring countries by calculating the
homozygosity index and the allele frequency suggesting a
more precise estimate of the overrepresentation of certain
HLA profiles within the Danish population.
Methods
HLA nomenclature and typing format
The WHO Nomenclature Committee for Factors of the
HLA System have published 19 major reports to date, doc-
umenting HLA antigens, genes and alleles in response to
the necessity for a systematic nomenclature for the poly-
morphic genes encoded in the HLA region. New alleles re-
ceive a unique identifier in the IPD-IMGT/HLA database
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(see below) after careful curation and analysis. These identi-
fiers are composed of up to four sets of two digits separated
by colons. The number of sets provided is often referred to
as resolution. At the lowest resolution, only the first set of
digits is provided (2-digit resolution), whereas a refined
characterization of an allele would contain four sets (8-digit
resolution), say HLA-A*02:01:01:02 L, that is an example of
a full resolution allele. The first set of digits (HLA-A*02)
defines the allele group as defined by a serological study of
the antigen carried by the allele. The second set of digits
(HLA-A*02:01, 4-digit resolution) defines an ordinal indi-
cating the sequential order in which different subtypes were
discovered. The third set of digits defines synonymous ex-
onic variants (6-digits, HLA-A*02:01:01). Finally, the high-
est resolution level corresponds to alleles harbouring
variants in untranslated regions such as those in introns, or
in the 5′ or 3′ UTRs (8-digits, HLA-A*02:01:01:02). There
are additional optional suffixes to an allele to indicate its ex-
pression status, such as low (L) expression or null (N) ex-
pression (not considered in the analyses presented here).
Reference databases
IPD-IMGT/HLA
The IPD-IMGT/HLA database is part of the Inter-
national ImMunoGeneTics (IMGT) databases. It con-
tains sequences of the human major histocompatibility
complex (MHC) and includes the official sequences
named by the WHO Nomenclature Committee for Fac-
tors of the HLA System. This database contains 16,933
sequences and annotation information according to its
latest version report (3.28.0 of 2017-04), In addition to
the version report, monthly HLA Nomenclature updates
are released, both in journals and online [38].
Allele Frequency Net
The Allele Frequency Net database is currently main-
tained by the consortium of the NHS Trust and the Uni-
versity of Liverpool. It contains frequency information of
several immune genes such as Human Leukocyte Anti-
gens, Killer-cell Immunoglobulin -like Receptors, and
cytokines. Depending on the polymorphism, it contains
population frequencies at the allele, haplotype or geno-
type levels [39].
Common and Well-Documented Alleles
The Common and Well-Documented (CWD) alleles’
catalogue is supported by the National Marrow Donor
Program (US) and by Anthony Nolan (UK). The aim is
to identify subsets of HLA alleles for which the frequen-
cies are well known or have been validated multiple
times through sequencing-based typing methods. Alleles
are considered common when the frequency is observed
to be greater than 0.001 in reference populations of at
least 1500 individuals and reported more than three
times in unrelated individuals, respectively. Currently,
this catalogue is used in the National Marrow Donor
program as reference for rare alleles [40].
HLA typing methods
Optitype
Optitype works under the premise that the correct
genotype is the one that explains the source of more
reads than the rest of the genotypes. Hence, it finds the
allele combination that maximizes the number of ex-
plained reads. Optitype overcomes the limitations of
previous typers concerning ambiguous read alignment
and suboptimal performance due to the exclusion of in-
tronic information. For this, the custom database against
which the reads are mapped contains genomic informa-
tion that is limited to exons 2 and 3 together with small
flanking intronic regions reconstructed from partially se-
quenced alleles with small phylogenetic distances. Al-
though this database aims at improving typing, the
resolution is limited by design to 4-digit resolution by
the lack of extended genomic information. Also, the
method currently has only HLA class I reference infor-
mation readily available.
Polysolver
Polysolver is based on the reasoning that the coverage
at HLA regions can be improved by identifying reads
that failed to align to the canonical reference due to
the accumulation of variants in these very hypermut-
able regions, and performing a realignment of such
reads against a library of all known HLA alleles in
the IPD-IMGT/HLA database. Thus, Polysolver en-
ables high-precision HLA typing and mutation detec-
tion using the inferred alleles as a basis for said
mutation. The method adopts a Bayesian classification
approach where the allele with the highest probability
is stored as the first correct allele and in a later iter-
ation, the probabilities are recalculated taking into ac-
count the results from the previous search and the
fact that the individual can be either heterozygous or
homozygous [33]. Polysolver provides full resolution
of up to 8-digits.
Allele reduction
The two aforementioned methods provide different reso-
lution levels. For comparison purposes, alleles must
present an identical resolution level. We converted iden-
tifiers of higher resolution than 4-digits using an allele
reduction step. This process eliminates the excessive
left-most pairs of numbers of the identifier, under the as-
sumption that 6-digit and 8-digit resolutions describe
variation of the same protein allele described at the level
of 4-digits. For example, an allele A*02:01:01:02 would
be converted to A*02:01 after allele reduction [41].
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The Genome Denmark cohort
The Genome Denmark cohort consists of 150 Danish
individuals arranged in 50 trios (father, mother and
child) [35]. Whole genome sequencing of these indi-
viduals was performed using Illumina technology at
BGI Europe in Copenhagen, with an average depth of
80X and read length of 100 bp. Importantly, for each
sample paired-end/mate-pair libraries were generated
at different insert sizes of 180 bp, 500 bp, 800 bp,
2000 bp, 5000 bp, 10,000 bp, and 20,000 bp allowing
for high quality assemblies, also of the highly poly-
morphic HLA region.
Trios in the Genome Denmark cohort were examined
for their familial relationships. The HumanCoreExome
BeadChip v.1.0 was used to genotype the trios using the
HiScan system (Illumina, San Diego, California). Geno-
types were called using GenomeStudio software (version
2011.1; Illumina). All subjects presented a high call rate
above 98% and all familial relationships were confirmed.
Members of two families failed to map to the database
used by Optitype and were therefore removed from the
initial analysis. Thus, our analysed cohort consists of 48
out of the initial 50 family trios.
HLA typing accuracy
To assess the confidence of the previously described
methods for the Genome Denmark cohort, two different
measures were defined for comparison. The Descent Ac-
curacy (DA) is defined as the number of alleles of the
progeny that can be explained by the typing of the par-
ent’s alleles. DA is defined as follows:
DA ¼ Neq
NAlleles
ð3:1Þ
where Neq is the number of alleles from the offspring
that are coherently explained by the inheritance from
the parents, and Nalleles the number of total alleles as de-
scribed in (Eq. 3.2):
NAlleles ¼ Nchildren  2  Locus ð3:2Þ
where Nchildren is the number of children in the popula-
tion, and Locus is the number of loci to test. Each child
carries two alleles per locus, one from each progenitor.
For the complete HLA class I region, comprising three
loci (HLA-A, -B and -C), every individual from the off-
spring would carry three times two alleles.
The Method Agreement (MA) measures the agree-
ments between the two prediction methods. MA is de-
fined as the number of identical alleles typed by the
different methods:
MA ¼ NOptitype ¼ NPolysolver
NPopulation  2  Locus ð3:3Þ
Extremely low MA values would indicate that the al-
leles tested differ enough from those of the database as
for the typers to not agree in the imputed allele. On the
other hand, high MA values as a measurement of identi-
cally typed alleles would mean an accurate representa-
tion of the alleles in the database used.
Population analysis
We initially produced an overview of the population
where firstly, the homozygosity ratio was compared with
the homozygosity rates in the general population. This
measurement is important because it is directly related
to the runs of homozygosity (ROH) [42], which are re-
gions of the genome that are identical despite having
been inherited from both mother and father. The exist-
ence of these ROH can be explained by intermarriage,
isolation and bottleneck situations, because the outcome
of them is usually consanguinity. A high homozygosity
rate can have medical consequences [43].
The homozygosity rate (HR) for alleles is described as
follows:
HR ¼ NHl
NPopulation
ð3:4Þ
where NHl is the number of homozygous individuals in
locus L. In this case, as the homozygosity implies a cer-
tain composition of the population, HR was tested for
parents. The genetic background of the parents is un-
defined and therefore, their alleles and their frequency,
are representative of the population. This is not the case
for the children, if their possible alleles are a small sub-
set defined by the alleles of the parents.
Then the allele frequency for each allele was calculated
using the direct counting method [44]. For measuring
the similarity with similar populations in terms of size
and geographical proximity, the computed frequencies
were compared to the information gathered in the two
databases “Allele Frequency Net” and “Common and
Well Documented Alleles” [39, 40].
Results
HLA typing
Here we used Optitype and Polysolver to type the individ-
uals in the 50 family trios in the Genome Denmark cohort
(150 individuals). HLA haplotypes are inherited in a Men-
delian manner where the presence of each of the two al-
leles observed in the children must be explained by the
presence of the same allele in either the mother or the
father. The disposition in trios facilitates the traceability of
the inheritance from parents to children. Due to typing
problems, two families were discarded for the following
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analysis. Table 1 compares the descendent accuracy (DA)
achieved by Optitype and Polysolver at different resolu-
tions. DA indicates the fraction of alleles explained by dir-
ect inheritance from the parents.
When predictions across all alleles (HLA-A, HLA-B
and HLA-C) are considered, Optitype produces coherent
results between parents and children (0.88) across the
144 individuals in the Genome Denmark cohort. This is
especially clear from the almost perfect (0.95) transmis-
sion of the predicted HLA-A alleles. The other two loci,
HLA-B and HLA-C, follow closely with a DA of 0.82
and 0.87, respectively.
Contrarily, Polysolver produces predictions at its default
8-digit resolution that do not always transmit coherently
from parents to children. DA ranges from 0.47 to 0.77,
with an overall coherence of 0.64. These results might in
part be explained by the increased number of possible al-
ternatives due to the higher resolution and secondly to
differences in complete, well assembled genomic regions
rather than exons as is the case for Optitype.
To correct for the differences in resolution between
the two methodologies, 8-digit typing results were col-
lapsed into their 4-digit counterparts using the allele re-
duction protocol described in Methods. After allele
reduction, Polysolver (4-digits) produced DA results that
outperform those produce by Optitype. Overall, DA rises
to 0.953. The largest improvement was observed for the
HLA-A locus, where DA reached 0.95, which constitutes
a 2-fold improvement. HLA-B and HLA-C followed with
a final DA of 0.95 and 0.96, respectively. Both Polysolver
and Optitype achieved similar HLA-A DA. Mismatched
alleles often belong to the same serological groups
(2-digits) than the correct types, in concordance with
observations by existing benchmarks in spite of the dif-
ferent evaluation approaches implemented [32]. In our
case, we evaluate the successful transfer of the sero-
logical group from parents to offspring while Kiyotani
et al. compare against experimentally determined HLA
alleles. Examples of incorrectly predicted alleles that still
lay within the same serological group can be found in
families 918 and 651 for Optitype, and families 1009 and
1030 for Polysolver, 8-digits. Interestingly, we find that
HLA-B alleles still represent a challenge. This is also in
agreement with previous observations [32]. In contrast
to existing analyses [31, 32], our results suggest that
Polysolver outperforms Optitype not only in the HLA-B
region, which is the most polymorphic and a priori the
most difficult to type, but also in its HLA-C counterpart.
This improvement may stem from the different data-
bases implemented by the methods; as the correct allele
would likely only be present in the most complete data-
base (Polysolver). Any small differences in the alignment
against a restricted database such as the one imple-
mented in Optitype would lead to incorrect typings.
As method-biases would affect all members of the fam-
ily in the same manner, high DA is not necessarily equiva-
lent to consistent predictions across two or more HLA
typing methods. This effect is aggravated by the fact that
the non-inherited alleles are not evaluated. To bridge this
gap, we calculated an alternative statistic, which we refer
to as method agreement (MA), to compare the complete
set of predicted alleles between the two methods. MA pro-
vides good grounds to evaluate consistency in the predic-
tions involving related individuals.
Typing accuracy across the methods (Polysolver and
Optitype, both at 4-digit resolution) was evaluated in
terms of MA. Overall, 63% of the alleles were congru-
ently typed by both methods (Table 2). Interestingly,
there were differences between the loci; HLA-A alleles
were the most correctly predicted alleles, followed by
HLA-B and HLA-C alleles. Furthermore, the majority of
the individuals were typed either with complete con-
cordance (6 identical alleles, 2 for each of the HLA-A,
HLA-B and HLA-C loci) or with one discordant allele
(Fig. 1). It is important to note that overall MA is mostly
affected by several families rather than individuals
(Fig. 1). Interestingly, we noticed that Polysolver had in-
corporated homozygous loci in almost all the wrongly
typed cases. One particularly odd family was not only in-
consistent between parents and offspring, but also in-
consistent between the methods. In this case, Polysolver
added many more homozygous sites than in other cor-
rectly typed loci. It is also worth noting how the discrep-
ancies in the DA differ between the methods. In
Optitype, the alleles wrongly typed according to the DA
method are, in all the cases, wrongly typed in their entir-
ety: not only do they not match at the allele level, but
they also have the wrong serotype (2-digits level). This is
Table 1 Descent Accuracy (DA) for the two typers considered
Typer Overall HLA-A HLA-B HLA-C
Polysolver (4-digit) 0.95 0.95 0.95 0.96
Optitype (4-digit) 0.88 0.95 0.82 0.87
Polysolver (8-digit) 0.64 0.47 0.68 0.77
Optitype at 4-digit resolution performed better than Polysolver having 8-digit
resolution. However, when allele reduction is applied Polysolver surpasses the
results provided by Optitype on the Genome Denmark cohort
Table 2 Method agreement (MA) across the different loci and
overall
Overall HLA-A HLA-B HLA-C
MATOTAL 0.63 0.65 0.60 0.62
MAT 0.62 0.63 0.60 0.64
MANT 0.63 0.67 0.60 0.60
MA represents the fraction of coherent alleles between Optitype and
Polysolver at 4-digit resolution. MATOTAL refers to the complete set of alleles.
MAT refers to the portion of alleles that are inherited from parent to child, and
MANT to those those that are not inherited and therefore, not part of the
DA calculation
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also the case with Polysolver with full resolution and
after allele reduction.
In family 1113, the alleles from HLA-A from the chil-
dren can be explained by the parents, but the alleles in-
ferred do not contribute to the MA as long as the
methods imputed different alleles, and these alleles share
neither 4- or 2-digit resolution. This is the case in sev-
eral other families (1426 and 714). For this, although the
typed alleles might be correct according to the DA, they
should not by definition be seen as contributing to MA.
One could argue that a source of error is the presence
of highly similar sequences in the database that would
represent a challenge for the methods to discern. In the
extreme case where two sequences are almost identical
to the genomic allele of interest, the choice would be
completely spurious and lack any biological information.
Such cases should count as reduced error. We assessed
the similarities between the sequences represented in
each reference database with BLAST. For each allele
considered by Optitype and Polysolver, we annotated the
identity to any other sequence in their respective data-
bases as provided by the method providers in the
method installation packages (Fig. 2). Optitype presents
a larger amount of sequences that align with more than
95% identity to other sequences of comparable length in
its own database than Polysolver. These results fit within
the description of the databases. Optitype sequences
span exons 2 and 3, and reconstructed intronic regions,
that are susceptible to be more similar than the whole
genomic region. This highlights the importance of
genomic databases instead of exonic, as the probability
of incorrectly imputed allele is higher in the latter, sim-
ply for similarity reasons.
Population analysis
The homozygosity rate accounts for the number of iden-
tical alleles in the same locus. This ratio is usually high
in small, isolated populations due to poor genetic admix-
ture; some specific allelic variants have evolved separ-
ately in ancestral genomes and display nowadays a
characteristic geographical profile.
We calculated homozygosity rates for the HLA alleles
identified in the parents of the Genome Denmark cohort
(Table 3). Results are highly coherent between methods and
although several individuals might present differential
individual typing, the population maintains its structure.
Overall, homozygosity rates are comparable between the
methods, albeit slightly higher after allele reduction for
Polysolver results. However, there are significant differences
between the different individual loci. For HLA-A loci, Poly-
solver with 8-digit resolution achieved the same homozy-
gosity rate as Optitype, while it was increased for the
Polysolver (4-digits). HLA-B presents the smallest variance
among the methods after performing allele reduction. In
spite of HLA-B being the most polymorphic, both typers
reached similar homozygosity rates. Both methods reached
the highest level of homozygosity in HLA-C loci, the least
polymorphic according to published results to date.
In addition to homozygosity rates, we computed the fre-
quency of the individual alleles. The frequency of HLA al-
leles, inherited from parents to offspring, is a powerful
tool in population genetics due to the population-wise
variation they display [45]. As can be seen from Table 4 in
the columns corresponding to the Genome Denmark co-
hort, although the frequencies are slightly different, the
proportions are quite stable between methods.
Compared to the expected allele frequency database
values, there are some discrepancies in the proportions
regarding the populations. While the most common al-
lele for HLA-B is B*07:02 and indeed is the most com-
mon in the Caucasian population according to the
database, the rest of the alleles typed by these methods
are rarely seen. For example, the second most common
allele in the Danish population according to Polysolver,
B*07:05, is not even present in a relevant proportion in
other related populations, where it is seldom observed
(Table 4). B*07:05 is also inconsistent between the ana-
lysed methods, where Optitype seems to favour B*08:01
instead. Upon reviewing the database used, we observed
that the B*08:01 allele is frequently represented, due to
extensive intronic reconstruction, whereas B*07:05 only
has six possible alleles. The mapping would naturally fail
in examples where differences would lie within the other
exonic/intronic regions or where the reconstructed
Fig. 1 Concordance between the two methods at the level of
individuals. The y-axis indicates the number of individuals, while the
x-axis shows the number of alleles per individual identically typed
for Optitype and Polysolver 4-D)
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regions were largely different to the real allele. In this
case, if B*07:05 and B*08:01 are similar, the probability
of Optitype wrongly aligning to either of them depends
on the number of available alleles and the similarities
among them.
We compared our results to those for known popula-
tions in the database of Common and Well-Documented
alleles [40]. For all the loci, the most common alleles are
those common to other historically connected populations
such as North Ireland, Sweden and Norway. This com-
parison considers sequence similarity but also similar pro-
portion in the population [46]. The rarer alleles, however,
have larger than expected proportions in our cohort,
suggesting that some of these alleles could indeed be
population specific.
Locus HLA-A is the one with most similarities among
closely related populations. The most common allele in
the Danish population according to both typers
(A*02:01) is also commonly found in populations within
the geographical proximity to Denmark, including
Sweden and Germany. This allele is also very prevalent
in other more distant populations. Similar proportions
for the least represented alleles are found across popula-
tions. Interestingly, the second most common allele
(A*01:01) has a frequency closer to historically related
settlements in Northern Ireland and England than to
countries with shared borders and similar genetic back-
ground. The third most common allele (A*03:01) has a
frequency dissimilar to any other and probably reflects
the homogeneity of the Danish population. HLA-C al-
leles also suggest similarities to the frequencies found in
Northern Ireland and England, which harboured known
Viking settlements, rather than to the countries in the
geographical vicinity.
Fig. 2 Blastn results of Optitype sequences against Optitype database (l) and Polysolver sequences against Polysolver database (r). In the
plots we can observe that the identity within Optitype is higher than within Polysolver. This stems from the nature of the database.
Optitype relies on a database with exons 2 and 3 and reconstructed introns, which produces sequences with scarce variation. As
expected, Polysolver, due to including genomic sequences, has more variance in the identity within sequences. The self-blasted results
(i.e. Sequence A against itself) were removed from the analysis
Table 3 Homozygosity Rates between methods
Typer Overall HLA-A HLA-B HLA-C
Optitype (4-digit) 0.09 0.08 0.08 0.11
Polysolver (8-digit) 0.08 0.08 0.02 0.14
Polysolver (4-digit) 0.12 0.12 0.09 0.15
Homozygosity Rates between methods, based on the number of identical
alleles in each locus, either HLA-A, HLA-B or HLA-C; or across all three (Overall)
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Again, the most dissimilar locus is HLA-B, and the
one where the biggest fluctuation of alleles is found. It
can be seen in the proportion of the most common al-
leles: HLA-B has less homogeneity in which alleles are
in the population, as if no allele HLA-B has been fixed.
This can either mean that the typing is wrong, which
could be the case regarding all previous results, or that
the HLA-B has not been decisive for the population.
Following the results above, if the alleles were indeed
rare, they should be indicated as such in the Common and
Well-Documented alleles database. The variety of different
alleles typed by Optitype is less significant than for Polysol-
ver. Among the methods, HLA-A and HLA-C were most
similar to other populations in terms of allele distribution.
In Fig. 3, both loci have some alleles that are common
(those that match other populations) but they also display
several rare alleles, those less frequent. As expected,
HLA-B has the highest rate of rare alleles, which confers
value to the results found in the homozygosity rate analysis.
Discussion
We have performed here a comprehensive analysis of the
HLA region in the Genome Denmark cohort, using two of
the available bioinformatics methods, Optitype and Poly-
solver. Our results show that in general, the two
HLA-typers compared reasonably well. Both methods
yielded an accuracy higher than 80% as observed in previ-
ous studies [22–24]. Our analysis yields results that differ
from existing benchmarks by Kiyotani et al. and Bauer
et al. We propose Polysolver as the most accurate typer for
4-digits resolution. Bauer et al. do not consider Polysolver
in their analysis due to technical limitations. Kiyotani et al.
perform an analysis on 12 clinical samples, whereas the
analysis presented here relies on 50 Danish parental trios.
The increased sample size may represent more accurately
the diversity of existing alleles.
Moreover, the study presented here is, to our know-
ledge, the first to compare WGS data between these two
typers. Both existing benchmarks evaluate comparisons
stemming mainly from WES data with a theoretical
4-digit resolution upper limit. Bauer and collaborators
expand further this limit to 6-digit and 8-digit resolution
by including RNAseq and simulated data, respectively
[31]. Nevertheless, using high-depth WGS data in com-
bination with family information, provides in our opin-
ion, two fundamental advantages: First, the agreement
between parents and children offers accuracy estima-
tions independent from the availability of curated gold
standard data. Second, HLA sequences are considered in
their whole extent, including intronic regions. These are
typically disregarded by other methods with reduced ac-
curacy in spite of their plausible functional relevance.
Table 4 Comparison of allele frequencies between different populations
Genome Denmark
Allele Northern Ireland Sweden (South) Sweden (North) Germany England (North) Basque Country Scotland Orkney Polysolver Optitype
A*02:01 0.27 0.26 0.24 0.28 0.29 0.27 NA [#1] 0.26 [#1] 0.24
A*01:01 0.20 0.09 0.08 0.15 0.21 NA NA [#2] 0.21 [#2] 0.22
A*03:01 0.14 0.25 0.31 0.15 0.14 NA NA [#3] 0.17 [#3] 0.17
A*24:02 NA 0.13 0.21 0.09 0.07 NA NA [#4] 0.09 [#5] 0.04
A*11:01 0.08 0.06 0.01 0.06 0.07 NA NA [#5] 0.04 < 0.04
A*23:01 0.01 NA NA 0.023 0.02 0.02 NA < 0.045 [#4] 0.05
B*07:02 0.17 0.19 0.19 0.12 0.15 NA NA [#1] 0.18 [#1] 0.18
B*07:05 10−3 NA NA 4 × 10−3 3 × 10−3 NA NA [#2] 0.15 < 0.06
B*15:01 0.04 0.14 0.15 0.06 0.06 NA NA [#3] 0.07 [#4] 0.09
B*44:02 0.13 0.10 0.03 0.07 0.10 NA 0.26 [#4] 0.07 [#3] 0.09
B*40:01 0.05 0.10 0.14 0.05 0.06 NA 0.06 [#5] 0.06 [#5] 0.06
B*08:01 0.16 0.07 0.05 0.09 0.15 NA 0.17 < 0.06 [#2] 0.13
C*07:01 NA NS NS 0.15 0.19 NA NA [#1] 0.19 [#1]0.2
C*07:02 0.19 NS NS 0.13 0.16 NA NA [#2] 0.18 [#2] 0.17
C*06:02 0.09 NS NS 0.1 0.09 0.03 0.07 [#3] 0.11 [#4] 0.1
C*03:03 0.05 NS NS 0.05 0.06 0.07 0.09 < 0.08 [#3] 0.11
C*03:04 0.06 NS NS 0.07 0.08 0.05 0.05 [#4] 0.09 [#5] < 0.09
C*05:01 0.13 NS NS 0.06 0.10 0.14 5 × 10−3 [#5] 0.08 0.09
Comparison of allele frequencies between different historically related populations through settlements (Northern Ireland, England, Scotland Orkney), geo-graphically
nearness (Sweden, Germany) and not related (Basque Country). The “NA” value means that the particular allele is either not present in the population or not significant.
“NS” means there is no data for this allele in the corresponding study. The top five most frequent alleles for each loci per method are included for the Genome Demark
cohort. The alleles marked with “#” indicate the order of said allele in the ranking of the most common alleles
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In terms of performance, the correct choice of a refer-
ence database remains as the main challenge. Probabilis-
tically, larger databases are in disadvantage against
limited databases in terms of assessing correctly among
the alleles represented. Despite this consideration, Poly-
solver produces better results after reduction of the reso-
lution to levels comparable to those produced by
Optitype. Furthermore, it can be argued that the typing
from Polysolver, as derived from a more complete data-
base, is more reliable, as Optitype in its simplicity might
not be typing the right allele.
The main drawback of Optitype is that it relies on a
curated database that mainly contains exons and a lim-
ited number of flanking introns. A genomic region can
be fairly similar to another one in the exonic part, espe-
cially if it belongs to the same serotype, but differ greatly
in several other parts of the sequence. This would hinder
the comparison between methods that provide different
default resolutions: while Polysolver uses a statistical
model, Optitype applies a simpler alignment-based
method. Polysolver in its highest resolution also gives an
insight into the importance of having the most complete
database. In general, and considering that the bench-
marked methods were the currently best ones, we can
say that no available method is accurate for the highest
level of resolution.
Homozygosity ratios are also useful for describing a
population. In principle, the high homozygosity imputed
to this cohort can be explained by the cohort itself, as the
individuals have been chosen to be representatives of an
ancestral Danish population. In our results, the homozy-
gosity ratio provided by Polysolver is higher after allele re-
duction (4-digits) than when using 8-digits resolution.
These results are as expected, especially if the differences
between alleles are exclusively located in intronic regions.
For Optitype, the results are very similar. This has bio-
logical relevance. The 4-digit resolution at the protein
level, includes differences in protein-coding regions. In
homogeneous populations, the advantageous alleles are
fixed. In HLA, the advantage of an allele lies in the bind-
ing groove in exons 2 and 3, so similar homozygosity ra-
tios from both typers are expected. Interestingly, the most
homozygous locus, HLA-C, is also the locus with the low-
est MA. These two discrepancies together might indicate
that there is no correct allele in the database for the
HLA-C alleles of the cohort, but very similar ones only.
With the population analysis, we addressed the genetic
similarity between populations. In general, Danes resem-
ble historically related population in the frequency of the
most common alleles, but not to countries in the geo-
graphical vicinity. It is more noticeable for HLA-B,
where the difference between the most common allele
Fig. 3 Distribution of alleles according to CWD for Polysolver (a) and Optitype (b). These results highlight that HLA- B harbours the rarest alleles
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and the rest are larger than in any of the other loci, in
addition to the differences between methods. These dif-
ferences can be largely due to the representation of the
alleles in the database. For Optitype, B*08:01 is overrep-
resented in comparison with B*07:05. As the Optitype
method of imputation is based on the number of reads
mapped to a specific allele, a higher number of alleles
from the same 4-digits group increases the probability of
overrepresentation.
Conclusion
HLA genetics is as complex as it is useful. The HLA re-
gion is important not only for transplantation, but it has
also been related to a myriad of autoimmune diseases and
cancer and used in many other research fields such as
population genetics. The usefulness of the genes in this
part of the genome is directly related to our ability to
identify correctly the alleles that each individual has. So
far, the molecular genetics methods have been the gold
standard, but the recent advances in sequencing and bio-
informatics approaches can shift views towards what not
also emerges in the personalized medicine field.
These approaches, though, are still in their infancy.
While HLA class I alleles are less complex to type, they
have been extensively used as proof of concept for differ-
ent typing approaches as the ones compared here. In
spite of that, only Polysolver has achieved an accuracy
similar to those already reported in the previous bench-
marks, indicating that there is still room for improve-
ment in the field. Previous benchmarks highlighted the
importance of larger, more diverse databases. Our results
in a distinct homogeneous population are coherent also
support that view. Also, if these methods aim for being
used in clinic, future tools need to incorporate the HLA
class II region, and probably, HLA class III. The current
methods, however imperfect, are a step in the right dir-
ection. Although the accuracy is not as high as previous
authors have claimed using with the gold standard, the
studied typers are somewhat robust, as they have man-
aged to type accurately a different cohort, which holds
new variation within their genetic sequences [34].
Despite the robustness, the amount of new data and
alleles being added every day to the database, new
GWAS and novel studies about mismatch in donor or-
gans are leaving the 4-digits typing obsolete. Current
methods have problems of underperformance when
dealing with the ever-expanding list of alleles, as we and
other researcher have brought forward bioinformatics ef-
forts and whole genome sequencing cohorts like Gen-
ome Denmark are an invaluable source of information
for these databases. Similar efforts in isolated or geo-
graphically remote populations are an interesting field of
research, and the information from them important if
these techniques are to replace PCR-based methods.
In conclusion, assuming that the quality of reference
databases increases steadily in the future, algorithmic
changes are urgently needed. The rapid growth of the
number of alleles, the new NGS methods and the new
studies disregarding the acceptable mismatches for
organ donation, typers should include the whole data-
base of available HLA alleles [47], and better methods of
imputation.
Abbreviations
CWD: Common and Well-Documented; DA: Descendent accuracy;
HLA: Human leukocyte antigen; HR: Homozygosity rate;
IMGT: International ImMunoGeneTics; MA: Method Agreement;
MHC: The major histocompatibility complex; NGS: Next-generation
sequencing; ROH: Runs of homozygosity
Funding
This work has been supported by grants from the Novo Nordisk Foundation
(NNF17OC0027594 and NNF14CC0001) and the Innovation Fund Denmark
(5184-00102B).
Availability of data and materials
The sequencing data used in our analyses was published [35] and are
publicly available in the European Genome-phenome Archive under acces-
sion number EGAS00001002108 (https://ega-archive.org/studies/
EGAS00001002108). These include individual sequence data, alignment based
assemblies and the complete variant call-set in the form of a phased VCF file.
Authors’ contributions
MLMH, JMGI and SB conceived and designed the experiments, MLMH
carried out the experiments. MLMH, JMGI and SB wrote the manuscript. All
authors have read and approved the final version of this manuscript.
Authors in the Danish Pan-Genome Consortium
Lasse Maretty,5 Jacob Malte Jensen,6,7 Bent Petersen,8 Jonas Andreas Sibbesen,5
Siyang Liu,5,9 Palle Villesen,6,7,10 Laurits Skov,6,7 Kirstine Belling,8 Christian Theil
Have,11 Jose M.G. Izarzugaza,8 Marie Grosjean,8 Jette Bork-Jensen,11 Jakob
Grove,7,12,13 Thomas D. Als,7,12,13 Shujia Huang,14,15 Yuqi Chang,14 Ruiqi Xu,9 Weijian
Ye,9 Junhua Rao,9 Xiaosen Guo,14,16 Jihua Sun,9,11 Hongzhi Cao,14 Chen Ye,14 Johan
v Beusekom,8 Thomas Espeseth,17,18 Esben Flindt,16 Rune M. Friborg,6,7 Anders E.
Halager,6,7 Stephanie Le Hellard,18,19 Christina M. Hultman,20 Francesco Lescai,7,12,13
Shengting Li,7,12,13 Ole Lund,8 Peter Løngren,8 Thomas Mailund,6,7 Maria Luisa
Matey-Hernandez,8 Ole Mors,7,10,13 Christian N.S. Pedersen,6,7 Thomas Sicheritz-
Pontén,8 Patrick Sullivan,20,21 Ali Syed,8 David Westergaard,8 Rachita Yadav,8 Ning
Li,9 Xun Xu,14 Torben Hansen,11 Anders Krogh,5 Lars Bolund,12,14 Thorkild I.A.
Sørensen,11,22,23 Oluf Pedersen,11 Ramneek Gupta,8 Simon Rasmussen,8 Søren
Besenbacher,6,10 Anders D. Børglum,7,12,13 Jun Wang,7,14,16 Hans Eiberg,24 Karsten
Kristiansen,14,16 Søren Brunak,8,25 Mikkel Heide Schierup6,7,26,
5 Bioinformatics Centre, Department of Biology, University of Copenhagen,
2200 Copenhagen N, Denmark
6 Bioinformatics Research Centre, Aarhus University, 8000 Aarhus C, Denmark
7 iSEQ, Centre for Integrative Sequencing, Aarhus University, 8000 Aarhus C,
Denmark
8 DTU Bioinformatics, Department of Bio and Health Informatics, Technical
University of Denmark, Kemitorvet, 2800 Kongens Lyngby, Denmark
9 BGI-Europe, Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark
10 Department of Clinical Medicine, Aarhus University, 8000 Aarhus C,
Denmark
11 Novo Nordisk Foundation Center for Basic Metabolic Research, Section of
Metabolic Genetics, University of Copenhagen, 2100 Copenhagen Ø,
Denmark
12 Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark
13 The Lundbeck Foundation Initiative for Integrative Psychiatric Research,
iPSYCH, Denmark
14 BGI-Shenzhen, Shenzhen 518083, China
15 School of Bioscience and Biotechnology, South China University of
Technology, Guangzhou 510006, China
Matey-Hernandez et al. BMC Bioinformatics  (2018) 19:239 Page 10 of 12
16 Laboratory of Genomics and Molecular Biomedicine, Department of
Biology, University of Copenhagen, 2100 Copenhagen Ø, Denmark
17 Department of Psychology, University of Oslo, Norway
18 NORMENT, KG Jebsen Centre for Psychosis Research, Department of
Clinical Science, University of Bergen, Bergen, 5021, Norway
19 Dr. E. Martens Research Group of Biological Psychiatry, Center for Medical
Genetics and Molecular Medicine, Haukeland University Hospital, Bergen,
5021, Norway
20 Department of Medical Epidemiology and Biostatistics, Karolinska
Institutet, Stockholm, 17177, Sweden
21 Department of Genetics, University of North Carolina, Chapel Hill, NC
27599–7264, USA
22 Department of Clinical Epidemiology (formerly Institute of Preventive
Medicine), Bispebjerg and Frederiksberg Hospital, The Capital Region,
Copenhagen, Denmark
23 Department of Public Health, Faculty of Health and Medical Sciences,
University of Copenhagen, Copenhagen, Denmark
24 Department of Cellular and Molecular Medicine, University of
Copenhagen, 2200 Copenhagen N, Denmark
25 Novo Nordisk Foundation Center for Protein Research, Faculty of Health
and Medical Sciences, University of Copenhagen, 2200 Copenhagen N,
Denmark
26 Department of Bioscience, Aarhus University, 8000 Aarhus C, Denmark
Ethics approval and consent to participate
The parent–offspring trios (mother–father–child) in the Danish Pan-Genome
were selected from the Copenhagen Family Bank [35, 48]. The study protocol
was reviewed and approved by The Danish National Committee on Health
Research Ethics (file number 1210920, submission numbers 36615 and
38259), as described in [36].
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Center for Biological Sequence Analysis, Department of Bio and Health
Informatics, Technical University of Denmark, DK-2800 Lyngby, Denmark.
2Department of Twin Research and Genetic Epidemiology, Kings College
London, London, UK. 3Novo Nordisk Foundation Center for Protein Research,
Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200
Copenhagen, Denmark.
Received: 1 March 2018 Accepted: 12 June 2018
References
1. Wilson J, Hunt T. T cells and MHC proteins. In: Molecular biology of the cell.
4th ed. New York: Garland Science; 2002. p. 711.
2. Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate
immune system. Nat Immunol. 2015;16(4):343–53.
3. Ayala Garcia MA, Gonzalez Yebra B, Lopez Flores AL, Guani Guerra E. The major
histocompatibility complex in transplantation. J Transp Secur. 2012;2012:7.
4. Fitch WM, Ayala FJ, National Academy of Sciences (U.S.). Molecular Genetics
of Speculation and Human Origins. In: Tempo and mode in evolution:
genetics and paleontology 50 years after Simpson. Washington, D.C.:
National Academy Press; 1995. p. viii, 325.
5. Trowsdale J, Knight JC. Major histocompatibility complex genomics and
human disease. Annu Rev Genomics Hum Genet. 2013;14:301–23.
6. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ,
Povey S, Talbot CC Jr, Wright MW, et al. Gene map of the extended human
MHC. Nat Rev Genet. 2004;5(12):889–99.
7. Doytchinova IA, Guan P, Flower DR. Identifiying human MHC supertypes
using bioinformatic methods. J Immunol. 2004;172(7):4314–23.
8. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, Worning P,
Sylvester-Hvid C, Lamberth K, Roder G, Justesen S, et al. Definition of
supertypes for HLA molecules using clustering of specificity matrices.
Immunogenetics. 2004;55(12):797–810.
9. Nielsen M, Lundegaard C, Worning P, Hvid CS, Lamberth K, Buus S, Brunak
S, Lund O. Improved prediction of MHC class I and class II epitopes using a
novel Gibbs sampling approach. Bioinformatics. 2004;20(9):1388–97.
10. Shiina T, Hosomichi K, Inoko H, Kulski JK. The HLA genomic loci map:
expression, interaction, diversity and disease. J Hum Genet. 2009;54(1):15–39.
11. Carlini F, Ferreira V, Buhler S, Tous A, Eliaou J-F, Rene C, Chiaroni J, Picard C,
Di Cristofaro J. Association of HLA-A and non-classical HLA class I alleles.
PLoS One. 2016;11(10):e0163570.
12. Kochan G, Escors D, Breckpot K, Guerrero-Setas D. Role of non-classical MHC
class I molecules in cancer immunosuppression. Oncoimmunology. 2013;
2(11):e26491.
13. Garstka MA, Fish A, Celie PH, Joosten RP, Janssen GM, Berlin I, Hoppes R,
Stadnik M, Janssen L, Ovaa H, et al. The first step of peptide selection in
antigen presentation by MHC class I molecules. Proc Natl Acad Sci U S A.
2015;112(5):1505–10.
14. Lund O, Nascimento EJM, Maciel M Jr, Nielsen M, Larsen MV, Lundegaard C,
Harndahl M, Lamberth K, Buus S, Salmon J, et al. Human leukocyte antigen
(HLA) class I restricted epitope discovery in yellow fewer and dengue
viruses: importance of HLA binding strength. PLoS One. 2011;6(10):e26494.
15. Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding
of MHC class I and MHC class II antigen presentation. Nat Rev Immunol.
2011;11(12):823–36.
16. Evseeva I, Nicodemus KK, Bonilla C, Tonks S, Bodmer WF. Linkage
disequilibrium and age of HLA region SNPs in relation to classic HLA gene
alleles within Europe. Eur J Hum Genet. 2010;18(8):924–32.
17. Fernandez Vina MA, Hollenbach JA, Lyke KE, Sztein MB, Maiers M, Klitz W, Cano P,
Mack S, Single R, Brautbar C, et al. Tracking human migrations by the analysis of
the distribution of HLA alleles, lineages and haplotypes in closed and open
populations. Philos Trans R Soc Lond Ser B Biol Sci. 2012;367(1590):820–9.
18. Stranzl T, Larsen MV, Lund O, Nielsen M, Brunak S. The cancer exome
generated by alternative mRNA splicing dilutes predicted HLA class I
epitope density. PLoS One. 2012;7(9):e38670.
19. Brorsson C, Tue Hansen N, Bergholdt R, Brunak S, Pociot F. The type 1
diabetes - HLA susceptibility interactome–identification of HLA genotype-
specific disease genes for type 1 diabetes. PLoS One. 2010;5(3):e9576.
20. Sheldon S, Poulton K. HLA typing and its influence on organ
transplantation. Methods Mol Biol. 2006;333:157–74.
21. Rees L, Kim JJ. HLA sensitisation: can it be prevented? Pediatr Nephrol. 2015;
30(4):577–87.
22. Boegel S, Lower M, Schafer M, Bukur T, de Graaf J, Boisguerin V, Tureci O,
Diken M, Castle JC, Sahin U. HLA typing from RNA-Seq sequence reads.
Genome Med. 2012;4(12):102.
23. Bai Y, Ni M, Cooper B, Wei Y, Fury W. Inference of high resolution HLA
types using genome-wide RNA or DNA sequencing reads. BMC
Genomics. 2014;15:325.
24. Kim HJ, Pourmand N. HLA haplotyping from RNA-seq data using
hierarchical read weighting. PLoS One. 2013;8(6):e67885.
25. Szolek A, Schubert B, Mohr C, Sturm M, Feldhahn M, Kohlbacher O.
OptiType: precision HLA typing from next-generation sequencing data.
Bioinformatics. 2014;30(23):3310–6.
26. Mahdi BM. A glow of HLA typing in organ transplantation. Clin Transl Med.
2013;2(1):6.
27. Tinckam KJ. Basic histocompatibility testing methods. In: Chandraker A,
Sayegh MH, Singh AK, editors. Core concepts in renal transplantation.
Boston: Springer US; 2012. p. 21–42.
28. Dunckley H. HLA typing by SSO and SSP methods. Methods Mol Biol. 2012;
882:9–25.
29. Schmitz JL. HLA typing using molecular methods. In: Coleman WB,
Tsongalis GJ, editors. Molecular diagnostics: for the clinical laboratorian.
Totowa: Humana Press; 2005. p. 485–93.
30. La Manna G, Corsini S, Iannelli S, Cappuccilli ML, Comai G, Iorio M,
Todeschini P, Carretta E, Scolari MP, Bontadini A, et al. Influence of the
immunogenetic KIR and HLA systems on long-term renal transplant
outcome. Ann Transplant. 2013;18:611–21.
31. Bauer DC, Zadoorian A, Wilson LO, Melbourne Genomics Health A, Thorne
NP. Evaluation of computational programs to predict HLA genotypes from
genomic sequencing data. Brief Bioinform. 2016;19(2):179–87.
Matey-Hernandez et al. BMC Bioinformatics  (2018) 19:239 Page 11 of 12
32. Kiyotani K, Mai TH, Nakamura Y. Comparison of exome-based HLA class I
genotyping tools: identification of platform-specific genotyping errors.
J Hum Genet. 2017;62(3):397–405.
33. Shukla SA, Rooney MS, Rajasagi M, Tiao G, Dixon PM, Lawrence MS, Stevens
J, Lane WJ, Dellagatta JL, Steelman S, et al. Comprehensive analysis of
cancer-associated somatic mutations in class I HLA genes. Nat Biotechnol.
2015;33(11):1152–8.
34. Besenbacher S, Liu S, Izarzugaza JM, Grove J, Belling K, Bork-Jensen J, Huang S,
Als TD, Li S, Yadav R, et al. Novel variation and de novo mutation rates in
population-wide de novo assembled Danish trios. Nat Commun. 2015;6:5969.
35. Maretty L, Jensen JM, Petersen B, Sibbesen JA, Liu S, Villesen P, Skov L, Belling
K, Theil Have C, Izarzugaza JMG, et al. Sequencing and de novo assembly of
150 genomes from Denmark as a population reference. Nature. 2017;548:87.
36. Jensen JM, Villesen P, Friborg RM, Danish Pan-Genome C, Mailund T,
Besenbacher S, Schierup MH, Maretty L, Jensen JM, Petersen B, et al.
Assembly and analysis of 100 full MHC haplotypes from the Danish
population. Genome Res. 2017;27(9):1597–607.
37. Athanasiadis G, Cheng JY, Vilhjalmsson BJ, Jorgensen FG, Als TD, Le Hellard
S, Espeseth T, Sullivan PF, Hultman CM, Kjaergaard PC, et al. Nationwide
genomic study in Denmark reveals remarkable population homogeneity.
Genetics. 2016;204(2):711–22.
38. Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG. The IPD
and IMGT/HLA database: allele variant databases. Nucleic Acids Res. 2015;
43(Database issue):D423–31.
39. Gonzalez-Galarza FF, Takeshita LY, Santos EJ, Kempson F, Maia MH, da Silva
AL, Teles e Silva AL, Ghattaoraya GS, Alfirevic A, Jones AR, et al. Allele
frequency net 2015 update: new features for HLA epitopes, KIR and disease
and HLA adverse drug reaction associations. Nucleic Acids Res. 2015;
43(Database issue):D784–8.
40. Mack SJ, Cano P, Hollenbach JA, He J, Hurley CK, Middleton D, Moraes ME,
Pereira SE, Kempenich JH, Reed EF, et al. Common and well-documented HLA
alleles: 2012 update to the CWD catalogue. Tissue Antigens. 2013;81(4):194–203.
41. Marsh SGE. Nomenclature for factors of the HLA system, update April 2016.
Int J Immunogenet. 2016;2016(43):310–3.
42. Kirin M, McQuillan R, Franklin CS, Campbell H, McKeigue PM, Wilson JF.
Genomic runs of homozygosity record population history and
consanguinity. PLoS One. 2010;5(11):e13996.
43. Bittles AH. Consanguinity and its relevance to clinical genetics. Clin Genet.
2001;60(2):89–98.
44. Shen C, Zhu B, Liu M, Li S. Genetic polymorphisms at HLA-A, -B, and -DRB1
loci in Han population of Xi’an city in China. Croat Med J. 2008;49(4):476–82.
45. Sanchez-Mazas A, Meyer D. The relevance of HLA sequencing in population
genetics studies. J Immunol Res. 2014;2014(1):971818.
46. McEvoy B, Brady C, Moore LT, Bradley DG. The scale and nature of Viking
settlement in Ireland from Y-chromosome admixture analysis. Eur J Hum
Genet. 2006;14(12):1288–94.
47. Tinckam KJ, Rose C, Hariharan S, Gill J. Re-examining risk of repeated HLA
mismatch in kidney transplantation. J Am Soc Nephrol. 2016;27(9):2833–41.
48. Eiberg H, Nielsen LS, Klausen J, Dahlen M, Kristensen M, Bisgaard ML, Moller
N, Mohr J. Linkage between serum cholinesterase 2 (CHE2) and gamma-
crystallin gene cluster (CRYG): assignment to chromosome 2. Clin Genet.
1989;35(5):313–21.
Matey-Hernandez et al. BMC Bioinformatics  (2018) 19:239 Page 12 of 12
